These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37446631)

  • 21. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric Modulators of Dopamine D
    Kaczor AA; Wróbel TM; Bartuzi D
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of substance use disorder on oxidative and antioxidative stress markers: A systematic review and meta-analysis.
    Viola TW; Orso R; Florian LF; Garcia MG; Gomes MGS; Mardini EM; Niederauer JPO; Zaparte A; Grassi-Oliveira R
    Addict Biol; 2023 Jan; 28(1):e13254. PubMed ID: 36577724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Beta-Adrenergic Receptors in Depression and Resilience.
    Zhang H; Cui M; Cao JL; Han MH
    Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct brain structural abnormalities in attention-deficit/hyperactivity disorder and substance use disorders: A comparative meta-analysis.
    Long Y; Pan N; Ji S; Qin K; Chen Y; Zhang X; He M; Suo X; Yu Y; Wang S; Gong Q
    Transl Psychiatry; 2022 Sep; 12(1):368. PubMed ID: 36068207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
    Zhao F; Cheng Z; Piao J; Cui R; Li B
    Front Pharmacol; 2022; 13():947785. PubMed ID: 36059987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of enkephalinergic systems in substance use disorders.
    Rysztak LG; Jutkiewicz EM
    Front Syst Neurosci; 2022; 16():932546. PubMed ID: 35993087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies.
    Zeraatkar D; Cooper MA; Agarwal A; Vernooij RWM; Leung G; Loniewski K; Dookie JE; Ahmed MM; Hong BY; Hong C; Hong P; Couban R; Agoritsas T; Busse JW
    BMJ Open; 2022 Aug; 12(8):e054282. PubMed ID: 35926992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the association between khat use and psychiatric symptoms: a systematic review.
    Edwards B; Atkins N
    BMJ Open; 2022 Jul; 12(7):e061865. PubMed ID: 35879018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis.
    Baranyi G; Fazel S; Langerfeldt SD; Mundt AP
    Lancet Public Health; 2022 Jun; 7(6):e557-e568. PubMed ID: 35660217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cocaine: An Updated Overview on Chemistry, Detection, Biokinetics, and Pharmacotoxicological Aspects including Abuse Pattern.
    Roque Bravo R; Faria AC; Brito-da-Costa AM; Carmo H; Mladěnka P; Dias da Silva D; Remião F; On Behalf Of The Oemonom Researchers
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between alexithymia and substance use: A systematic review and meta-analysis.
    Honkalampi K; Jokela M; Lehto SM; Kivimäki M; Virtanen M
    Scand J Psychol; 2022 Oct; 63(5):427-438. PubMed ID: 35436351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mathematical model of reward-mediated learning in drug addiction.
    Chou T; D'Orsogna MR
    Chaos; 2022 Feb; 32(2):021102. PubMed ID: 35232044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mood and Anxiety Symptoms in Persons Taking Prescription Opioids: A Systematic Review with Meta-Analyses of Longitudinal Studies.
    Leung J; Santo T; Colledge-Frisby S; Mekonen T; Thomson K; Degenhardt L; Connor JP; Hall W; Stjepanović D
    Pain Med; 2022 Aug; 23(8):1442-1456. PubMed ID: 35167694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A coordinate-based meta-analysis of white matter alterations in patients with alcohol use disorder.
    Spindler C; Mallien L; Trautmann S; Alexander N; Muehlhan M
    Transl Psychiatry; 2022 Jan; 12(1):40. PubMed ID: 35087021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis.
    Regan A; Margolis S; de Wit H; Lyubomirsky S
    PLoS One; 2021; 16(10):e0258849. PubMed ID: 34695117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community?
    Florou D; Boumba VA
    Toxicol Rep; 2021; 8():1699-1720. PubMed ID: 34646750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol and the Risk of Injury.
    Chikritzhs T; Livingston M
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-Response Relationships between Levels of Alcohol Use and Risks of Mortality or Disease, for All People, by Age, Sex, and Specific Risk Factors.
    Rehm J; Rovira P; Llamosas-Falcón L; Shield KD
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular insights into the biased signaling mechanism of the μ-opioid receptor.
    Cong X; Maurel D; Déméné H; Vasiliauskaité-Brooks I; Hagelberger J; Peysson F; Saint-Paul J; Golebiowski J; Granier S; Sounier R
    Mol Cell; 2021 Oct; 81(20):4165-4175.e6. PubMed ID: 34433090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.